Delivery Order SPE2DB24D1205-SPE2DB25FCVTW

Award Date 4/10/25
Potential Completion Date 5/1/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,743.80 firm fixed-price delivery order is for 240 mg/24 ml vials of the drug Opdivo, with a period of performance through November 28, 2023. The contract is not designated as a set-aside and represents an award under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $77,575.80, is for the delivery of 240 mg/24 ml vials of the medication Opdivo. The award is a delivery order under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 and running through November 2026. This IDC serves as the...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $24,446.28 firm fixed-price contract is for the delivery of 240 mg/24 ml vials of the drug Opdivo. The order has an ultimate completion date of November 3, 2023. AmerisourceBergen holds a substantial $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $26,765.90 firm fixed-price delivery order is for the supply of 240 mg/24 ml vials of the cancer medication Opdivo. The contract has an ultimate completion date of August 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,257.68 firm fixed-price contract is for the supply of 100 mg/10 ml vials of the drug Opdivo, with a performance period ending on April 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,813.58 fixed-price contract is for the delivery of 240 mg/24 ml vials of the medication Opdivo. The contract has an ultimate completion date of June 12, 2025 and is not a set-aside award. Amerisourcebergen Drug Corp is also the prime contractor on a larger $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,955.85 firm fixed-price delivery order covers the supply of 240 mg/24 ml vials of the cancer medication Opdivo. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a...
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $26,765.90, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,097.77 firm fixed price delivery order is for the pharmaceutical product OPDIVO 240 MG/24 ML VIAL 24ML. The contract has an ultimate completion date of June 6, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,782.51 firm fixed-price delivery order is for OPDIVO 240 MG/24 ML VIAL 24ML and has an ultimate completion date of April 11, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 that serves as a primary vehicle for providing a...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCVTW
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,906.79 firm fixed-price delivery order is for the supply of 240 mg/24 ml vials of the medication Opdivo, with a period of performance through May 1, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract allows for multiple delivery orders across different therapeutic categories, positioning AmerisourceBergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The contract award is not designated as a set-aside.

Generated 7/17/25, 6:31 PM